SPA Microgen (part of Nacimbio Holding of Rostec State Corporation) registered four new indications for RELATOX in Uzbekistan. Now the entire range of uses of this drug is available to consumers from the Republic of Uzbekistan, as in Russia.
Read more
SPA Microgen (part of Nacimbio Holding of Rostec State Corporation) has received the approval of the Ministry of Health of Kyrgyzstan for the application of the RELATOX drug in the territory of the Republic for two new indications – treatment of chronic migraine and correction of neck wrinkles.
Read more
The Russian Ministry of Health has approved the expansion of indications for the use of botulinum toxin type A Relatox by SPA ‘Microgen’ (part of Nacimbio Holding of Rostec State Corporation) for the treatment of focal spasticity of arm muscles in adults.
Read more
